Abstract
Several pieces of evidence indicate that, in neurological disorders associated with immune activation, brain infiltrating macrophages and microglial cells secrete various neurotoxic factors, such as glutamate and reactive oxygen species, which may greatly influence the survival of neurons (Mallat and Chamak, 1994; Giulian et al., 1993; Stone, 1993). Among the putative endogenous neurotoxins released by phagocytic cells during inflammatory processes, particular attention has been devoted to quinolinic acid (QUIN) (Heyes et al., 1993; Heyes, 1993). This tryptophan metabolite, formed along the kynurenine pathway, exerts its effect through activation of glutamate NMDA receptors and its accumulation within the CNS, observed in brain inflammatory disorders, has been speculatively linked to neuronal dysfunctions (Heyes et al., 1993). The overproduction of QUIN is mainly attributed to the induction of indoleamine-2,3 dioxygenase (IDO), the enzyme converting L-tryptophan into L-kynurenine (Takikawa et al., 1988; Taylor and Feng, 1991), by cytokines, such as IFN-γ. It has been found that IFN-γ activated human macrophages are able to produce QUIN directly from L-tryptophan (Heyes et al., 1992), whereas neurons and astroglial cells, even if they express inducible IDO activity (Saito et al., 1993a), do not appear to synthesise this neurotoxin directly from L-tryptophan. Whereas most of the available findings suggest that the large increase in QUIN cerebral levels in brain inflammatory conditions is mainly due to infiltrating activated macrophages, the relevance of activated microglial cells in the production of neuroactive kynurenines, has been only partially investigated (Saito et al., 1993a).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberati-Giani D., Malherbe P., Köhler C., Lang G., Kiefer V., Lahm H.-W., and Cesura A.M., 1995, Cloning and characterization of a soluble kynurenine aminotransferase from rat brain:identity with kidney cysteine conjugate ß-lyase, J. Neurochem.64:1448.
Foster A.C., White R.J., and Schwarcz R., 1986, Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro, J. Neurochem.47:23.
Giulian D., Vaca K., and Corpuz M., 1993, Brain glia release factors with opposing actions upon neuronal survival, J. Neurosci.13:29.
Heyes M.P., 1993, Metabolism and neuropathologic significance of quinolinic acid and kynurenic acid, Biochem. Soc. Trans.21:83.
Heyes M.P., Saito K., and Markey S.P., 1992, Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid, Biochem J. 283:633.
Heyes M.P., Saito K., Major E.O., Milstein S., Markey S.P., and Vickers J.H., 1993, A mechanism of quinolinic acid formation in inflammatory neurological diseases, Brain116:1425.
Mallat M., and Chamak B., 1994, Brain macrophages:.neurotoxic or neurotophic effectorcells?, J.Leuk. Biol.56:416.
Pellicciari R., Natalini B., Costantino G., Mahmoud M.R., Mattoli L., Sadeghpour B.M., Moroni F., Chiarugi A., and Carpenedo R., 1994, Modulation of the kynurenine pathway in search of new neuroprotective agents. Synthesis andpreliminary evaluation of (m-Nitrobenzoyl)alanine, a potent inhibitor of kynurenine 3-hydroxylase, J. Med. Chem.37:647.
Pirami L., Stockinger B., Betz-Corradin S., Sironi M., Sassano M., Valsasnini M., Righi M., and Ricciardi Castagnoli P., 1991, Mouse macrophage clones immortalized by retroviruses are functionally hetero-geneous, Proc. Natl. Acad. Sci. USA88:7543.
Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S.D., and Ricciardi-Castagnoli P., 1989, Monokine production by microglial cell clones, Eur. J. Immunol.19:1443.
Saito K., Chen C.Y., Masana M., Crowley J.F., Markey S.P., and Heyes M.P., 1993a, 4-Chloro-3-hydroxyan- thranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-g stimulated monocytes (THP-1 cells), Biochem. J. 291:11.
Saito K., Crowley J.S., Markey S.P., and Heyes M.P., 1993b, A mechanism for increased quinolinic acid formation following acute systemic immune stimulation, J. Biol. Chem.268:1.
Stone T.W., 1993, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev.45:309.
Takikawa O., Kuroiwa T., Yamazaki F., andKido R., 1988, Mechanism of interferon-γ action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-y and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity, J. Biol. Chem.263:2041.
Taylor M.W., and Feng G., 1991, Relationship between interferon-y, indoleamine 2,3-dioxygenase, and tryptophan catabolism, FASEB, 5:2516.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Alberati-Giani, D., Ricciardi-Castagnoli, P., Köhler, C., Cesura, A.M. (1996). Regulation of the Kynurenine Pathway by IFN-γ in Murine Cloned Macrophages and Microglial Cells. In: Filippini, G.A., Costa, C.V.L., Bertazzo, A. (eds) Recent Advances in Tryptophan Research. Advances in Experimental Medicine and Biology, vol 398. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0381-7_28
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0381-7_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8026-9
Online ISBN: 978-1-4613-0381-7
eBook Packages: Springer Book Archive